NCT07075159 Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
| NCT ID | NCT07075159 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Janice Hernandez, MD |
| Condition | Wound Healing |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-02-28 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-02-28 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.
Eligibility Criteria
Inclusion Criteria: * Patients \>18 years of age * follow-up at specified intervals (1 week/6 week/3 months) in an office setting * can give informed consent * no patients will be excluded on the basis of gender, ethnicity, or religious background Exclusion Criteria: * Patients \<18 years of age or \>100 * allergy to pectin, gelatin, and sodium carboxymethylcellulose * adults with impaired consent capacity * incarcerated individuals.
Contact & Investigator
Janice Hernandez, MD
PRINCIPAL INVESTIGATOR
University of Kentucky
Frequently Asked Questions
Who can join the NCT07075159 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Wound Healing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07075159 currently recruiting?
Yes, NCT07075159 is actively recruiting participants. Contact the research team at dampier@uky.edu for enrollment information.
Where is the NCT07075159 trial being conducted?
This trial is being conducted at Lexington, United States.
Who is sponsoring the NCT07075159 clinical trial?
NCT07075159 is sponsored by Janice Hernandez, MD. The principal investigator is Janice Hernandez, MD at University of Kentucky. The trial plans to enroll 20 participants.